The Heart Failure Drugs Market growth is driven by rising cardiovascular disease incidence, technological advancements, and patient awareness. Growth is mainly fueled by increased adoption of SGLT2 inhibitors, ARNI, and beta-blockers for managing chronic and acute heart failure. Improved formulations, targeted therapies, and combination regimens contribute to enhanced patient outcomes, which in...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek